Beste apotheek van Nederland

Stolk E A, Busschbach J J, Caffa M et al. Cost utility analysis of
sildenafil compared with papaverine-phentolamine
injections.[see comment]. BMJ 2000;320(7243):1165-1168.
Strachan M W, Teoh W L, Don-Wauchope A C et al. Clinical
and radiological features of patients with macroprolactinaemia.
Clin Endocrinol (Oxf) 2003;59(3):339-346.
Strahilevitz J, Rahav G, Schroers H-J et al. An outbreak of
Phialemonium infective endocarditis linked to intracavernous
penile injections for the treatment of impotence. Clin Infect Dis
2005;40(6):781-786.
Stroberg P, Murphy A, Costigan T. Switching patients with
erectile dysfunction from sildenafil citrate to tadalafil: results of
a European multicenter, open-label study of patient preference.
Clin Ther. 2003;25(11):2724-2737.
Struthers A D. Aldosterone blockade in heart failure. J Renin
Angiotensin Aldosterone Syst 2004;5(SUPPL. 1):S23-S27.
Stuckey B G A. Tadalafil phase 3 experience. European Urology
Supplements 2002;1(8):25-30.
Suetomi T, Endo F, Takeshima H et al. Evaluation of the
effectiveness of sildenafil using questionnaire methods versus
audio-visual sexual stimulation. Int J Urol 2005;12(4):369-373.
Suzuki F, Shimizu C, Umetsu M et al. Adult-onset idiopathic
hypogonadotropic hypogonadism due to isolated pituitary
gonadotropin deficiency. Adv Intern Med 2004;43(7):571-574.
Svartberg J, Aasebo U, Hjalmarsen A et al. Testosterone
treatment improves body composition and sexual function in
men with COPD, in a 6-month randomized controlled trial..
Respir Med 2004;98(9):906-913.
Swartz D A, Todd M W. Intracavernous papaverine and
glaucoma.[see comment]. JAMA 1990;264(5):570
Szucs A, Janszky J, Barsi P et al. Sleep-related painful erection
is associated with neurovascular compression of basal forebrain
[5]. J Neurol 2002;249(4):486-487.
T'Sjoen G, Feyen E, De Kuyper P et al. Self-referred patients in
an aging male clinic: much more than androgen deficiency
alone. Aging Male 2003;6(3):157-165.
Tam S W, Worcel M, Wyllie M. Yohimbine: a clinical review.
[Review] [152 refs]. Pharmacol Ther 2001;91(3):215-243.
Tarhan F, Canguven O, Kuyumcuoglu U. Intracavernous sodium
nitroprusside (SNP) versus papaverine/phentolamine in erectile
dysfunction: a comparative study of short-term efficacy and
side-effects.[comment]. Br J Sex Med 2006;3(2):377
Tarhan F, Kuyumcuoglu U, Kolsuz A et al. Effect of
intracavernosal sodium nitroprusside in impotence. Urol Int
1996;56(4):211-214.
Tas A, Dilek K, Gullulu M et al. Treatment of erectile
dysfunction in hemodialysis patients and effects of
sildenafil [abstract]. XXXVIII Congress of the
European Renal Association European Dialysis &
Transplant Association June 24-27 2003;2001,
Vienna, Austria 131p. 2003.
Taylor M J, Rudkin L, Hawton K. Strategies for
managing antidepressant-induced sexual dysfunction:
Systematic review of randomised controlled trials. J
Affect.Disord. 2005;88(3):241-254.
Teillac P, Bono A V, Irani J et al. The role of
luteinizing hormone-releasing hormone therapy in
locally advanced prostate cancer and biochemical
failure: Considerations for optimal use. Clin Ther
2005;27(3):273-285.
Teloken P E, Smith E B, Lodowsky C et al. Defining
association between sleep apnea syndrome and erectile
dysfunction. Urology 2006;67(5):1033-1037.
Thadani U, Smith W, Nash S et al. The effect of
vardenafil, a potent and highly selective
phosphodiesterase-5 inhibitor for the treatment of
erectile dysfunction, on the cardiovascular response to
exercise in patients with coronary artery disease. J Am
Coll Cardiol 2002;40(11):2006-2012.
Thaveundayil J X, Hambalek R, Ng Ying et al.
Prolonged penile erections induced by hydroxyzine:
Possible mechanism of action. Neuropsychobiology
1994;30(1):4-6.
Thrasher J B. What's new in urology. J Am Coll Surg
2005;201(3):438-448.
Tindall B, Forde S, Goldstein D et al. Sexual
dysfunction in advanced HIV disease. AIDS Care
1994;6(1):105-107.
Tomlinson J. Viagra and its use in cardiovascular
disease.[erratum appears in J Hum Hypertens 2000
Apr;14(4):283]. [Review] [11 refs]. J Hum Hypertens
1999;13(9):593-594.
Tomova A, Kumanov P. Are dehydroepiandrosterone
sulphate and lipids associated with erectile
dysfunction? [References]. Maturitas 2005;50(4):294­
299.
Tordjman G. NO/Pg E1: a new association in the
treatment of erectile impotence. Contracept Fertil Sex
(Paris) 1993;.21, pp.509-510, 1993.
Tosti A, Pazzaglia M, Soli M et al. Evaluation of
sexual function with an international index of erectile
function in subjects taking finasteride for androgenetic
alopecia.[see comment]. Arch Dermatol
2004;140(7):857-858.
D-152